101 - 120 of 141 Results
Young Leadership Council Q&A: Meet Your Co-Chairs Jenny Sorin and Erika Stallings
Girls Just Wanna Have…Healthcare Equity
Ovarian Cancer Research Update
Black & BRCA
LATINOS & BRCA
LATINOS & BRCA
Open Clinical Trials
BRCA in Women
Grants Program
BRCA in Men
BRCA in the Jewish Population
Insurance & Costs
Seguros y costos
Celebrating Five Years of Progress
2017 marks an important milestone for the Basser Center for BRCA: it’s our five year anniversary as the first comprehensive center and global hub for the research, treatment, and prevention of BRCA-related cancers.
Reveal Your #InvisibleGenes
The Basser Center is raising awareness about hereditary cancer through our #INVISIBLEGENES social media campaign and we need your help! The traits we inherit from our family define and connect us in countless ways. Sometimes these traits are obvious, like curly hair or dimples. But sometimes what we inherit remains hidden, like BRCA gene mutations which can increase your risk for developing certain type of cancers.
Young Leadership Council Profile: Kevin Kucharski
In this month’s profile, get to know Basser Young Leadership Council member Kevin Kucharski, a BRCA2 mutation carrier and medical student.
#PhiladelphiaPhil Celebrates 100 Years with the Eagles & Other Exciting News
Phil Basser, patriarch of the Basser family, has recently made it into the news for his legendary love of the Philadelphia Eagles.
New PARP Inhibitor Trial for BRCA1/2 and PALB2-Related Pancreatic Cancer
A phase II clinical trial that began in August of 2017, “A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation,” is enrolling patients at the Hospital of the University of Pennsylvania.
Basser Global Prize
Knowledge is Power: Understanding and Managing BRCA-Related Cancer
On January 25, the Basser Center for BRCA, UJA-Federation of New York, and the 92nd Street Y teamed up in New York City to present a panel on BRCA mutations and the latest lifesaving information surrounding hereditary cancers.